4,5-DEHYDRO DHA

CAS NO.：660429-97-0
Empirical Formula: C22H30O2
Molecular Weight: 326.47
MDL number: MFCD02259378
SAFETY DATA SHEET (SDS)
Update Date: 2025-04-17 18:22:24

What is 4,5-DEHYDRO DHA?

Description

Docosahexaenoic acid (DHA; 22:6ω3) is one of the essential dietary ω-3 unsaturated fatty acids and the preferred n-3 fatty acid for development of the brain and retina.¹ 4,5-dehydro DHA is a novel analog of DHA in which the double bond closest to the carboxyl group has been converted into an acetylene. 4,5-dehydro DHA is a novel compound that has not been studied in biological systems. However, the corresponding acetylene in the C-20 fatty acid series (5,6-dehydro arachidonic acid) is a well known inhibitor of 5-lipoxygenase.²

What are the applications of Application

4,5-dehydro Docosahexaenoic Acid is a novel analog of DHA

Definition

ChEBI: 4,5-dehydro Docosahexaenoic Acid is a very long-chain fatty acid.

References

1. Anderson, G.J., Connor, W.E., and Corliss, J.D. Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina Pediatr. Res. 27,89-97(1990).
2. Sok, D.E., Han, C.Q., Pai, J.K., et al. Inhibition of leukotriene biosynthesis by acetylenic analogs Biochem. Biophys. Res. Commun. 107,101-108(1982).

Properties of 4,5-DEHYDRO DHA

solubility

0.1 M Na2CO3: 1.7 mg/ml; DMF: >100 mg/ml; DMSO: >100 mg/ml; Ethanol: Miscible

Safety information for 4,5-DEHYDRO DHA

Computed Descriptors for 4,5-DEHYDRO DHA

New Products

Methyl N-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-N-nitroso-L-valinate Levofloxacin - Impurity B/ Levofloxacin Related Compound A Ivabradine R isomer Escitalopram - Impurity K Escitalopram Cyno dilol Impurity Paroxetine EP impurity I/Paroxetine Anhydrous EP Impurity I 2-Amino-5-Bromo-6-Chloropyridine 3-Amino-5-bromopicolinic acid 1-(7,8-Dinitro-4,5-dihydro-1H-1,5-methanobenzo[d]azepin-3(2H)-yl)-2,2,2-trifluoroethanone 2-Amino-3-Bromo-5-Cyanopyridine 2-Amino-3-Chloropyridine 2,5-Dibromo-3-Methylpyridine